A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men with Castration Resistant Metastatic Prostate Cancer: The TRANSFORMER Trial (Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance)

Grant

Date/time Interval

  • January 1, 2015 - September 29, 2017

    • Awarded By

    Total Award Amount

  • 308040.00

    • Direct Costs

  • 209550.00

    • Sponsor Award Id

  • 2002495982

    • Contributor

  • Mollie Deshazo M.D.   Investigator